RGNX
NASDAQ · Biotechnology
Regenxbio Inc
$9.84
+0.62 (+6.72%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+87.8% upside
Low Target
$13.35
Average Target
$18.48
High Target
$24.09
Current Price
$9.84
Current
$9.84
$9.84
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Scenario Analysis
Bear Case
$13.35
35.7%
Low target
Base Case
$18.48
+87.8%
Avg target
Bull Case
$24.09
+144.8%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$16.19
-39.2% from high
52-Week Low
$6.89
+42.8% from low
Target vs 52W High
$18.48
+14.1% vs high
Next Earnings Report
May 14, 2026 · After Market Close
3d
until earnings
EPS Est: $-1.37
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |